Advanced research on vasculogenic mimicry in cancer

Vasculogenic mimicry (VM) is a brand‐new tumour vascular paradigm independent of angiogenesis that describes the specific capacity of aggressive cancer cells to form vessel‐like networks that provide adequate blood supply for tumour growth. A variety of molecule mechanisms and signal pathways participate in VM induction. Additionally, cancer stem cell and epithelial‐mesenchymal transitions are also shown to be implicated in VM formation. As a unique perfusion way, VM is associated with tumour invasion, metastasis and poor cancer patient prognosis. Due to VM's important effects on tumour progression, more VM‐related strategies are being utilized for anticancer treatment. Here, with regard to the above aspects, we make a review of advanced research on VM in cancer.

• Publication year

  2015

• Venue

  Journal of Cellular and Molecular Medicine

• Publication date

  2015-01-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jcmm.12496PMID 25598425PMCID 4407602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Journal of Cellular and Molecular Medicine

  2014cited by this paper
• The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer.

  2014cited by this paper
• Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.

  2014cited by this paper
• Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma

  2013cited by this paper
• Basal caspase-3 activity promotes migration, invasion, and vasculogenic mimicry formation of melanoma cells

  2013cited by this paper
• Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis.

  2013cited by this paper
• Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity.

  2013cited by this paper
• Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma

  2013cited by this paper
• Molecular Pathways Molecular Pathways : Vasculogenic Mimicry in Tumor Cells : Diagnostic and Therapeutic Implications

  2012cited by this paper
• Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells

  2012cited by this paper
• FRMD4A upregulation in human squamous cell carcinoma promotes tumor growth and metastasis and is associated with poor prognosis.

  2012cited by this paper
• Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry

  2012cited by this paper
• Vasculogenic mimicry is a key prognostic factor for laryngeal squamous cell carcinoma: a new pattern of blood supply.

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Proliferative versus apoptotic functions of caspase-8 Hetero or homo: the caspase-8 dimer controls cell fate.

  2012cited by this paper
• Periodic acid Schiff loops and blood lakes associated with metastasis in cutaneous melanoma

  2012cited by this paper
• Zinc finger E‐box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial‐to‐mesenchymal transition

  2012cited by this paper
• Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines.

  2012cited by this paper
• Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology

  2012cited by this paper
• Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry

  2012cited by this paper
• SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.

  2012cited by this paper
• Conservation of caspase substrates across metazoans suggests hierarchical importance of signaling pathways over specific targets and cleavage site motifs in apoptosis

  2012cited by this paper
• BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells

  2012cited by this paper
• Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis.

  2012cited by this paper
• Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma

  2011cited by this paper
• Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro

  2011cited by this paper
• Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

  2011cited by this paper
• Role of hCG in Vasculogenic Mimicry in OVCAR-3 Ovarian Cancer Cell Line

  2011cited by this paper
• Cyclooxygenase-2 upregulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer

  2011cited by this paper
• Angiogenic signaling aberrantly induced by tumor hypoxia.

  2011cited by this paper
• VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: present and future.

  2011cited by this paper
• Molecular mechanisms and clinical applications of angiogenesis

  2011cited by this paper
• Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

  2011cited by this paper
• Microvilli expressed on glioma cells keep cytotoxic cells at a distance

  2011cited by this paper
• Twist2 contributes to breast cancer progression by promoting an epithelial–mesenchymal transition and cancer stem-like cell self-renewal

  2011cited by this paper
• Basic and therapeutic aspects of angiogenesis.

  2011cited by this paper
• Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer

  2011cited by this paper
• Curcumin: A component of the golden spice, targets multiple angiogenic pathways

  2011cited by this paper
• IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Signalling pathways in vasculogenic mimicry.

  2010cited by this paper
• Vasculogenic Mimicry: a New Prognostic Sign of Gastric Adenocarcinoma

  2010cited by this paper
• Glioblastoma stem-like cells give rise to tumour endothelium

  2010cited by this paper
• A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry.

  2010cited by this paper
• Expression and functional significance of Twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry

  2010cited by this paper
• miR-200a Regulates Epithelial-Mesenchymal to Stem-like Transition via ZEB2 and β-Catenin Signaling*

  2010cited by this paper
• Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma.

  2010cited by this paper
• Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.

  2010influential reference
• Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1

  2010cited by this paper
• Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

  2009cited by this paper
• Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.

  2009cited by this paper
• Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix–loop–helix Id2 (inhibitor of DNA binding 2)

  2009cited by this paper
• EphA2 as a promoter of melanoma tumorigenicity

  2009cited by this paper
• Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.

  2009cited by this paper
• Prognostic Role of Vasculogenic Mimicry in Colorectal Cancer

  2009cited by this paper
• Vasculogenic mimicry of acute leukemic bone marrow stromal cells

  2009cited by this paper
• Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

  2009cited by this paper
• Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.

  2008cited by this paper
• Identification of cells initiating human melanomas

  2008cited by this paper
• Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro.

  2008cited by this paper
• Functional significance of VEGF-a in human ovarian carcinoma: Role in vasculogenic mimicry

  2008cited by this paper
• N-Glycans in cancer progression.

  2008cited by this paper
• Role of nodal signaling and the microenvironment underlying melanoma plasticity

  2008cited by this paper
• CASP3 Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck

  2008cited by this paper
• A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

  2007cited by this paper
• Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: Role of the Eph receptors

  2007cited by this paper
• Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo

  2007cited by this paper
• The involvement of apoptosis in melanoma vasculogenic mimicry

  2007cited by this paper
• Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

  2007cited by this paper
• Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma.

  2007cited by this paper
• Current and future status of prostate cancer chemoprevention

  2006cited by this paper
• Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification

  2006cited by this paper
• Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.

  2006cited by this paper
• Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification

  2006cited by this paper
• Functional implication of BMP4 expression on angiogenesis in malignant melanoma

  2006cited by this paper
• VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: Implications for vasculogenic mimicry

  2006cited by this paper
• Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness

  2006cited by this paper
• Focal Adhesion Kinase Signaling and the Aggressive Melanoma Phenotype

  2006cited by this paper
• A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells

  2006cited by this paper
• Tumour plasticity and extravascular circulation in ECV304 human bladder carcinoma cells.

  2006cited by this paper
• Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions.

  2006cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005cited by this paper
• A tumorigenic subpopulation with stem cell properties in melanomas.

  2005cited by this paper
• Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer.

  2005cited by this paper
• Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor

  2005cited by this paper
• Requirement for caspase-8 in NF-kappaB activation by antigen receptor.

  2005cited by this paper
• Focal adhesion kinase promotes the aggressive melanoma phenotype.

  2005influential reference
• Does Vasculogenic Mimicry Exist in Astrocytoma?

  2005cited by this paper
• Membrane localization of all class I PI 3‐kinase isoforms suppresses c‐Myc‐induced apoptosis in Rat1 fibroblasts via Akt

  2005cited by this paper
• Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells

  2005cited by this paper
• Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.

  2004cited by this paper
• Somatic mutations of CASP3 gene in human cancers

  2004cited by this paper
• Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry.

  2004cited by this paper
• Role of tissue factor in hemostasis, thrombosis, and vascular development.

  2004cited by this paper
• Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Extracellular functions of galectin-3

  2004cited by this paper

• KDM6B promotes VEGFA expression and vasculogenic mimicry in glioblastoma cells under hypoxia conditions

  2026cites this paper
• Roles of lncRNA in the crosstalk between osteogenesis and angiogenesis in the bone microenvironment

  2025cites this paper
• Evidence for a JAK2/STAT3 proinflammatory and vasculogenic mimicry interrelated molecular signature in adipocyte-derived mesenchymal stromal/stem cells

  2025cites this paper
• Vascular mimicry developments in non-small cell lung cancer.

  2025cites this paper
• Targeting focal adhesion kinase inhibits cell migration and non-angiogenic vascularization in malignant breast cancer

  2025cites this paper
• Construction of a whole-brain panorama for glioma vasculature reveals tumor heterogeneity and blood-brain barrier disruption

  2025cites this paper
• Angiogenesis causes and vasculogenic mimicry formation in the context of cancer stem cells.

  2025cites this paper
• C‐mannosylation promotes ADAMTS1 activation and secretion in human testicular germ cell tumor NEC8 cells

  2025cites this paper
• Cancer-associated fibroblasts expressing FSTL3 promote vasculogenic mimicry formation and drive colon cancer malignancy

  2025cites this paper
• Vasculogenic mimicry in non-small cell lung cancer: a systematic review

  2025cites this paper
• Caveolin-1 drives vasculogenic mimicry in lung adenocarcinoma through autophagy-mediated glycolytic reprogramming.

  2025cites this paper
• Innovative Therapeutic Delivery of Metastasis-Associated in Colon Cancer 1-Suppressing miRNA Using High Transmembrane 4 L6 Family Member 5-Targeting Exosomes in Colorectal Cancer Mouse Models

  2024cites this paper
• Inhibition of PD-L1 expression in non-small cell lung cancer may reduce vasculogenic mimicry formation by inhibiting the epithelial mesenchymal transformation process.

  2024cites this paper
• Hypomethylation‐associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation‐mediated degradation of SND1

  2024cites this paper
• Ruta graveolens, but Not Rutin, Inhibits Survival, Migration, Invasion, and Vasculogenic Mimicry of Glioblastoma Cells

  2024cites this paper
• Prognostic Influence of Galectin-1 in Gastric Adenocarcinoma

  2024cites this paper
• Engineered in vivo and in vitro tumor model recapitulates vasculogenic mimicry signatures in melanoma

  2024cites this paper
• CSF-1R promotes vasculogenic mimicry via epithelial-mesenchymal transition in nasopharyngeal carcinoma cells

  2023cites this paper
• L1CAM promotes vasculogenic mimicry formation by miR‐143‐3p‐induced expression of hexokinase 2 in glioma

  2023cites this paper
• VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation

  2023cites this paper
• Cancer‐associated fibroblasts contribute to the immunosuppressive landscape and influence the efficacy of the combination therapy of PD‐1 inhibitors and antiangiogenic agents in hepatocellular carcinoma

  2023cites this paper
• Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents

  2023cites this paper
• MiRNA-related metastasis in oral cancer: moving and shaking

  2023cites this paper
• Aryl azoles based scaffolds for disrupting tumor microenvironment.

  2023cites this paper
• Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K/AKT/mTOR signaling pathway.

  2023cites this paper
• Long Non-Coding RNAs in Venous Thromboembolism: Where Do We Stand?

  2023cites this paper
• An Overview of Angiogenesis in Bladder Cancer

  2023cites this paper
• Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients

  2023cites this paper
• Tumor suppressor CLCA1 inhibits angiogenesis via TGFB1/SMAD/VEGF cascade and sensitizes hepatocellular carcinoma cells to Sorafenib.

  2023cites this paper
• Editorial: Canine osteosarcoma as a model in comparative oncology: Advances and perspective

  2023cites this paper
• VE-cadherin-dependent vasculogenic mimicry-like tube formation in rheumatoid arthritic synovium

  2023cites this paper
• Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas

  2022cites this paper
• Vandetanib alters the tumoricidal capacity of human breast cancer stem cells via inhibiting vasculogenic capacity

  2022cites this paper
• Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells

  2022cites this paper
• Rhizoma Paridis saponins suppresses vasculogenic mimicry formation and metastasis in osteosarcoma through regulating miR-520d-3p/MIG-7 axis.

  2022cites this paper
• SPHK/HIF-1α Signaling Pathway Has a Critical Role in Chrysin-Induced Anticancer Activity in Hypoxia-Induced PC-3 Cells

  2022cites this paper
• Vasculogenic Mimicry-An Overview.

  2022cites this paper
• Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells

  2022influential citation
• MORPHOLOGICAL FEATURES OF TUMOR ANGIOGENESIS IN INVASIVE DUCTAL BREAST CANCER

  2022cites this paper
• PAX2 induces vascular-like structures in normal ovarian cells and ovarian cancer

  2022cites this paper
• Histochemical Staining of Vasculogenic Mimicry.

  2022cites this paper
• Vascular mimicry: A potential therapeutic target in breast cancer.

  2022cites this paper
• Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases

  2021cites this paper
• Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.

  2021cites this paper
• Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells

  2021cites this paper
• An Insight into the Anti-Angiogenic and Anti-Metastatic Effects of Oridonin: Current Knowledge and Future Potential

  2021cites this paper
• HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment

  2021cites this paper
• Clinical Efficacy and Safety of Angiogenesis Inhibitors: Sex Differences and Current Challenges.

  2021cites this paper
• Drosophila Accessory Gland: A Complementary In Vivo Model to Bring New Insight to Prostate Cancer

  2021cites this paper
• An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology

  2021cites this paper
• TRPS1 knockdown inhibits angiogenic vascular mimicry in human triple negative breast cancer cells

  2021cites this paper
• Molecular insights into phytochemicals-driven break function in tumor microenvironment.

  2021cites this paper
• MTDH in macrophages promotes the vasculogenic mimicry via VEGFA-165/Flt-1 signaling pathway in head and neck squamous cell carcinoma.

  2021cites this paper
• The predictive value of galectin-1 and vascular mimicry in the prognostic evaluation of patients with rectal cancer

  2021influential citation
• Botanical from Piper capense Fruit Can Help to Combat the Melanoma as Demonstrated by In Vitro and In Vivo Studies

  2021cites this paper
• New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells

  2021cites this paper
• Novel Iodine nanoparticles target vascular mimicry in intracerebral triple negative human MDA-MB-231 breast tumors

  2021cites this paper
• Establishment and verification of prognostic model for gastric cancer based on autophagy-related genes.

  2021cites this paper
• Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer.

  2021cites this paper
• Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells

  2020cites this paper
• Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers

  2020cites this paper
• Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy

  2020influential citation
• Recent advances on anti-tumor agents-loaded polymeric and lipid based nano-carriers for the treatment of brain cancer.

  2020cites this paper
• SOX7 blocks vasculogenic mimicry in oral squamous cell carcinoma.

  2020cites this paper
• Hold on or Cut? Integrin- and MMP-Mediated Cell–Matrix Interactions in the Tumor Microenvironment

  2020cites this paper
• An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells.

  2020cites this paper
• The EMT transcription factor, Twist1, as a novel therapeutic target for pulmonary sarcomatoid carcinomas

  2020cites this paper
• Vascular mimicry: Triggers, molecular interactions and in vivo models.

  2020cites this paper
• A novel definition of microvessel density in renal cell carcinoma: Angiogenesis plus vasculogenic mimicry

  2020cites this paper
• The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor.

  2020cites this paper
• Expression of AGGF1 and Twist1 in hepatocellular carcinoma and their correlation with vasculogenic mimicry.

  2020cites this paper
• Baicalein suppresses vasculogenic mimicry through inhibiting RhoA/ROCK expression in lung cancer A549 cell line.

  2020cites this paper
• Galectin-1 promotes vasculogenic mimicry in gastric adenocarcinoma via the Hedgehog/GLI signaling pathway

  2020cites this paper
• Vasculogenic mimicry

  2020cites this paper
• Supervillin promotes tumor angiogenesis in liver cancer

  2020cites this paper
• Molecular Insights and Novel Approaches For Targeting Tumor Metastasis.

  2020cites this paper
• Downregulation of astrocyte elevated gene-1 expression inhibits the development of vasculogenic mimicry in gliomas

  2020cites this paper
• Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting.

  2020cites this paper
• Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway

  2020cites this paper
• Forskolin promotes vasculogenic mimicry and invasion via Notch-1-activated epithelial-to-mesenchymal transition in syncytiolization of trophoblast cells in choriocarcinoma

  2020cites this paper
• Vasculogenic mimicry in carcinogenesis and clinical applications

  2020cites this paper
• VEGFR1-Targeted Contrast-Enhanced Ultrasound Imaging Quantification of Vasculogenic Mimicry Microcirculation in a Mouse Model of Choroidal Melanoma

  2020cites this paper
• Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma

  2020cites this paper
• Oncometabolite L‐2‐hydroxyglurate directly induces vasculogenic mimicry through PHLDB2 in renal cell carcinoma

  2020cites this paper
• The roles of MASPIN expression and subcellular localization in non-small cell lung cancer

  2020cites this paper
• Vascular mimicry: changing the therapeutic paradigms in cancer

  2020cites this paper
• PAX2 Induces Tubular-Like Structures in Normal and Ovarian Cancer Cells

  2020cites this paper
• LINC00265 targets miR-382-5p to regulate SAT1, VAV3 and angiogenesis in osteosarcoma

  2020cites this paper
• DNA-nanorobot-guided thrombin-inducing tumor infarction: raising new potential clinical concerns.

  2020cites this paper
• Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability in vitro and in vivo

  2019cites this paper
• Targeting Tumor Endothelial Cells with Nanoparticles

  2019cites this paper
• Iron (II) Polypyridyl Complexes as Antiglioblastoma Agents to Overcome the Blood-Brain Barrier and Inhibit Cell Proliferation by Regulating p53 and 4E-BP1 Pathways

  2019cites this paper
• Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.

  2019cites this paper
• cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.

  2019cites this paper
• Upregulation of nectin-4 is associated with ITGB1 and vasculogenic mimicry and may serve as a predictor of poor prognosis in colorectal cancer

  2019cites this paper
• Mechanical Branching and Channel Formation and Its Relevance to Biological Systems

  2019cites this paper
• The function of phenotypic plasticity in tumor cells

  2019cites this paper
• Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells

  2019cites this paper
• HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells

  2019cites this paper
• Vasculogenic mimicry in melanoma: molecular mechanisms and clinical significance

  2019cites this paper